• Exyte offers the new ExyCellR modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP).
• Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreactors, for low footprint and economic large-scale production of viral products.
• The combined offer enables users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to new disease outbreaks.

Brussels, Belgium, May 05, 2020 – Univercells Technologies, a global provider of next-generation bioprocess technologies, launches today.  Under this new brand, the company will focus on the commercialization of the product portfolio and will explore new technology developments to expand its position in the cell and gene therapy market.  

Exothera will partner with cell & gene therapy innovators to unlock their manufacturing potential by capitalizing on best-in-class manufacturing technologies and bioprocessing expertise.

Luxembourg, March 3, 2020 – C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, has expanded their advisory board with a new member. Consisting of well-respected pharmaceutical industry experts, the board provides strategic guidance on the progress and growth of the company via organic and M&A activities in the mid and long-term.